Investors have welcomed the move of Eli Lilly's decision to separate Elanco Animal Health business. Lilly stock hits a new 52-week high after the earnings announcement. David Ricks said, "As the responses to the Blueprint are considered, we are hopeful that progress will be made on implementing...
anonymous
Thread
biotech
davidricks
donald trump
drug price
elanco animal health
eli lilly
merck
novartis
pfizer
pharma